18 May 2013
Keywords: neurosearch, signs, 47m, deal, gw, denmark, signed
Article | 24 January 2000
NeuroSearch of Denmark has signed a deal, potentially worth $47 millionexcluding royalties, with Glaxo Wellcome for the antidepressant NS2389.
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.